CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 214.5 SEK
Market Cap: 5.1B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Gross Profit
kr493.8m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
14%
Elekta AB (publ)
STO:EKTA B
Gross Profit
kr6.8B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Gross Profit
kr590.3m
CAGR 3-Years
53%
CAGR 5-Years
53%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Gross Profit
kr14.5B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Gross Profit
kr4.7B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Gross Profit
kr239.7m
CAGR 3-Years
46%
CAGR 5-Years
29%
CAGR 10-Years
24%
No Stocks Found

CellaVision AB
Glance View

Market Cap
5.1B SEK
Industry
Health Care

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CEVI Intrinsic Value
268.65 SEK
Undervaluation 20%
Intrinsic Value
Price

See Also

What is CellaVision AB's Gross Profit?
Gross Profit
493.8m SEK

Based on the financial report for Sep 30, 2024, CellaVision AB's Gross Profit amounts to 493.8m SEK.

What is CellaVision AB's Gross Profit growth rate?
Gross Profit CAGR 10Y
14%

Over the last year, the Gross Profit growth was 15%. The average annual Gross Profit growth rates for CellaVision AB have been 11% over the past three years , 9% over the past five years , and 14% over the past ten years .

Back to Top